Article Information
History
- October 8, 2018.
Article Versions
- Version 1 (September 13, 2018 - 12:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mai Bdarny1,2,
- Manu Prasad1,2,
- Noa Balaban1,2,
- Joshua Ben-Zion2,3,
- Anat Bahat Dinur2,3,
- Reidar Grénman4,
- Limor Cohen1,2 and
- Moshe Elkabets1,2
- 1The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
- 2Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel
- 3Department of Otolaryngology-Head & Neck Surgery, Soroka University Medical Center, Beer-Sheva 84105, Israel
- 4Department of Otorhinolaryngology – Head and Neck Surgery, Turku University and Turku University Hospital
- Corresponding authors:
Moshe Elkabets, The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. Tel: +972-86428846 FAX: +972-86477626. Email: moshee{at}bgu.ac.il Limor Cohen, The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. Tel: +972-86428846 FAX: +972-86477626. Email: ayashli{at}post.bgu.ac.il
Posted October 08, 2018.
The AP-1 complex regulates AXL expression and determines sensitivity to PI3Kα inhibition in esophagus and head and neck squamous cell carcinoma
